Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
02/25/2010 | CA2735130A1 Compounds and methods for treating respiratory diseases |
02/25/2010 | CA2734126A1 Metal complex and manufacturing method therefor |
02/24/2010 | EP2155736A1 Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound |
02/24/2010 | EP2155683A2 Pyridone derivatives as p38a mapk inhibitors |
02/24/2010 | EP2155682A2 Salts of isophosphoramide mustard and analogs thereof |
02/24/2010 | EP2155681A1 Process for the preparation of compositions for modulating a kinase cascade and methods of use thereof |
02/24/2010 | EP2155680A1 Indanone derivatives that inhibit prolyl hydroxylase |
02/24/2010 | EP2155675A1 Kinase inhibitors, compositions thereof, and methods of use therewith |
02/24/2010 | EP2155643A1 Ire-1a inhibitors |
02/24/2010 | EP2155194A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
02/24/2010 | EP2029596B1 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same |
02/24/2010 | EP2001873B1 Active ingredient combinations with insecticidal properties |
02/24/2010 | EP1599448B1 Preparation of 3,6-dichloro-2-trichloromethylpyridine by vapor phase chlorination of 6-chloro-2-trichlormethylpyridine |
02/24/2010 | CN101657424A dual-acting antihypertensive agents |
02/24/2010 | CN101657423A Iminipyridine derivatives and their uses as microbiocides |
02/24/2010 | CN101654433A Method for N-alkylation of 2-pyridone |
02/24/2010 | CN101654432A Method for N-alkylation of 2-pyridone |
02/24/2010 | CN101654431A Method for synthesizing pyridine propiolic acid ester |
02/24/2010 | CN101654430A Broadband electron transport material and preparation and application |
02/24/2010 | CN100591745C 电致发光装置 Electroluminescent device |
02/24/2010 | CN100591676C 2- and 2,5-substituted phenylketo-enols |
02/24/2010 | CN100591671C Heteroarylcarbamoylbenzene derivative |
02/23/2010 | US7667043 Molecular structures with controllable electron conducting properties |
02/23/2010 | US7666884 N-(2-substituted phenyl)-N-methoxycarbamates and their preparation and use thereof |
02/23/2010 | US7666883 2-[(2-Chloro-5-methyl pyridine-3-yl)(hydroxy)methyl]acrylonitrile; against chloroquine sensitive and chloroquine resistant Plasmodium falciparum; treating malarial; chemical preparation |
02/23/2010 | US7666873 N-phenyl-(2R,5S)dimethylpiperazine derivative |
02/23/2010 | US7666866 Antithrombotic diamides |
02/23/2010 | US7666865 Calcium channel blockers |
02/23/2010 | US7666442 Topical compositions comprising benfotiamine and pyridoxamine |
02/23/2010 | CA2562216C Process for producing a trifluoro-3-buten-2-one compound |
02/23/2010 | CA2345146C Cyanophenyl derivative |
02/18/2010 | WO2010019828A1 Glucagon receptor antagonists |
02/18/2010 | WO2010019701A2 Diaryl urea derivatives |
02/18/2010 | WO2010019646A1 Sphingosine-1-phosphate (s1p) receptor antagonists and methods for use thereof |
02/18/2010 | WO2010019398A1 Two phase bioactive formulations |
02/18/2010 | WO2010018858A1 Organic sulfur compound, process for production of the same, and organic electroluminescence element utilizing the same |
02/18/2010 | WO2010018857A1 Method for producing amide derivative |
02/18/2010 | WO2010018714A1 Amide derivative, pest control agent containing the amide derivative and use of the pest control agent |
02/18/2010 | WO2010018113A2 Bi-aryl aminotetralines |
02/18/2010 | WO2010018109A2 Substituted aminotetralines |
02/18/2010 | US20100041894 Eco-friendly process for recovery of pyridine and/or its derivatives |
02/18/2010 | US20100041882 Methods for synthesis of acyloxyalkyl compounds |
02/18/2010 | US20100041717 N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
02/18/2010 | US20100041715 Sphingosine-1-phosphate (s1p) receptor antagonists and methods for use thereof |
02/18/2010 | US20100041714 Bi-aryl aminotetralines |
02/18/2010 | US20100041713 Substituted aminotetralines |
02/18/2010 | US20100041708 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for it's preparation |
02/18/2010 | US20100041683 Novel chain-breaking antioxidants |
02/18/2010 | US20100041656 Novel amide derivatives and medicinal use thereof |
02/18/2010 | US20100041653 Composition and methods for the design and development of metallo-enzyme inhibitors |
02/18/2010 | US20100040753 Flavor molecules |
02/18/2010 | CA2735392A1 Bi-aryl aminotetralines |
02/18/2010 | CA2734119A1 Two phase bioactive formulations |
02/18/2010 | CA2734104A1 Substituted aminotetralines |
02/18/2010 | CA2733970A1 Sphingosine-1-phosphate (s1p) receptor antagonists and methods for use thereof |
02/18/2010 | CA2733557A1 Amide derivative, pest control agent containing the amide derivative, and use of the amide derivative |
02/17/2010 | EP2154131A1 G protein-coupled receptor inhibitor and pharmaceutical product |
02/17/2010 | EP2154130A1 Pyridone compound |
02/17/2010 | EP2152671A1 Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders |
02/17/2010 | EP2152663A2 Tri-aryl compounds and compositions comprising the same |
02/17/2010 | EP2152256A2 Telomerase activating compounds and methods of use thereof |
02/17/2010 | EP1979321B9 Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them |
02/17/2010 | EP1377263B1 Novel dyeing composition for dyeing keratinous fibres comprising a particular dicationic diazo dye |
02/17/2010 | EP1347950B1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses |
02/17/2010 | CN101652347A Process for producing substituted methylamine compound and triazine derivative |
02/17/2010 | CN101648912A Continuous preparation method of 4-nitro-3,5-dimethylpyridine-N-oxide |
02/17/2010 | CN101648911A Purifying method of 4-nitro-3,5-dimethylpyridine-N-oxide |
02/17/2010 | CN101648910A Method for preparing 3,5-dimethylpyridine-N-oxide |
02/17/2010 | CN101648909A Method for preparing cyanopyridine by using chloropyridine under the catalysis of ligand-free palladium |
02/17/2010 | CN101648908A New water-soluble rare-earth organic chelate fluorescent probe and preparation method thereof |
02/17/2010 | CN101648907A Purifying method of 2-chloromethyl-4-methoxyl-3,5-dimethylpyridine chloride |
02/17/2010 | CN101648906A Insecticidal N-substituted sulfoximines |
02/17/2010 | CN101648905A Preparation method of 2- chloro-6-trichloromethyl pyridine |
02/17/2010 | CN101648904A Synthesis method of 2,3-difluoro-5-chloropyridine |
02/16/2010 | US7662987 Methods for synthesis of acyloxyalkyl compounds |
02/16/2010 | US7662974 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
02/16/2010 | US7662966 For example, 5-tert-Butyl-2-{2-[4-(1-methyl-piperidin-4-yl)-butoxy]-pyridin-4-yl}-1H-benzoimidazole; use in leukocyte recruitment inhibition, in modulating H4 receptor, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions |
02/16/2010 | US7662839 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders; e.g. {4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl}-acetic acid |
02/16/2010 | US7662822 Substituted azaquinazolines having an antiviral action |
02/16/2010 | CA2478183C Substituted amides |
02/16/2010 | CA2452918C New compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
02/16/2010 | CA2445329C 20-hydroxyeicosatetraenoic acid production inhibitors |
02/16/2010 | CA2442882C Sulphones which modulate the action of gamma-secretase |
02/16/2010 | CA2385081C Carboxylic acid compound and a medicament comprising it |
02/11/2010 | WO2010017350A1 Aminopyridine kinase inhibitors |
02/11/2010 | WO2010017343A2 Flupirtine hydrochloride maleic acid cocrystal |
02/11/2010 | WO2010017260A1 Tripyridyl carboxamide orexin receptor antagonists |
02/11/2010 | WO2010017060A1 Urea derivatives as antibacterial agents |
02/11/2010 | WO2010017051A1 Novel phenylamino isonicotinamide compounds |
02/11/2010 | WO2010015655A1 Cyclohexyl amide derivatives and their use as crf-1 receptor antagonists |
02/11/2010 | WO2010015613A1 Organic compounds |
02/11/2010 | WO2010015387A1 Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment |
02/11/2010 | WO2010015340A1 Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment |
02/11/2010 | US20100036130 Processes for producing cycloalkylcarboxamido-pyridine benzoic acids |
02/11/2010 | US20100036119 Fluorinating reagents and their preparation |
02/11/2010 | US20100036115 Novel Compositions for the Delivery of Negatively Charged Molecules |
02/11/2010 | US20100036102 Novel chelating agents and highly luminescent and stable chelates and their use |
02/11/2010 | US20100035938 Cooling Compounds |
02/11/2010 | US20100035936 Heterocyclyl substituted tetrahydronaphthalene derivatives as 5-ht7 receptor ligands |
02/11/2010 | US20100035930 UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa |